Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Hisse Senetlerindeki Sıralama #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Hisse Fiyatı
$42.98
Son senkronizasyon: 2024-06-21
Piyasa Değeri
$1.62B
Değişim (1 gün)
0.01%
Değişim (1 yıl)
0.00%
Ülke
IL
Ticaret Taro Pharmaceutical Industries Ltd. (TARO)

Kategori

Taro Pharmaceutical Industries Ltd. (TARO) için kazanç
Mar 2024 itibarıyla kazanç TTM: $82.67M
Taro Pharmaceutical Industries Ltd. şirketinin en son finansal raporlarına göre, mevcut kazancı $82.67M'dir. 2023 yılında şirket $38.21M kazanç elde etti, bu 2022 yılındaki $77.86M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Taro Pharmaceutical Industries Ltd. için kazanç geçmişi 1999 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $82.67M 0.00%
2024 $82.67M 116.33%
2023 $38.21M -50.92%
2022 $77.86M -119.91%
2021 $-391.07M -231.35%
2020 $297.73M -16.57%
2019 $356.85M 22.06%
2018 $292.37M -47.87%
2017 $560.80M -11.94%
2016 $636.82M 9.48%
2015 $581.68M 31.04%
2014 $443.91M 32.17%
2013 $335.86M 39.40%
2012 $240.93M 219.63%
2010 $75.38M 60.06%
2009 $47.09M 6.88%
2008 $44.06M 8.67%
2007 $40.55M -149.57%
2006 $-81.81M -1,221.57%
2005 $7.29M -205.21%
2004 $-6.93M -109.50%
2003 $72.96M 37.75%
2002 $52.96M 74.37%
2001 $30.37M 141.72%
2000 $12.57M 79.24%
1999 $7.01M 0.00%
Benzer şirketler veya rakipler için kazanç